Several bioinformatics-based analyses have identified angiogenesis-related genes (ARGs) as potential prognostic biomarkers for several cancers (8–10).However, it is unclear whether ARGs can be used as potential prognostic markers for CRC. This evidence concerns the gene SERPINA2 and colorectal carcinoma.